Sinovac Biotech Ltd. (SVA)
6.47
0.00 (0.00%)
USD |
NASDAQ |
Aug 25, 16:00
Sinovac Biotech Max Drawdown (5Y) : 25.46% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 25.46% |
| June 30, 2026 | 25.46% |
| May 31, 2026 | 25.46% |
| April 30, 2026 | 25.46% |
| March 31, 2026 | 25.46% |
| February 28, 2026 | 25.46% |
| January 31, 2026 | 25.46% |
| December 31, 2025 | 25.46% |
| November 30, 2025 | 25.46% |
| October 31, 2025 | 25.46% |
| September 30, 2025 | 25.46% |
| August 31, 2025 | 25.46% |
| July 31, 2025 | 25.46% |
| June 30, 2025 | 25.46% |
| May 31, 2025 | 25.46% |
| April 30, 2025 | 25.46% |
| March 31, 2025 | 25.46% |
| February 28, 2025 | 25.46% |
| January 31, 2025 | 25.46% |
| December 31, 2024 | 25.46% |
| November 30, 2024 | 25.46% |
| October 31, 2024 | 25.46% |
| September 30, 2024 | 25.46% |
| August 31, 2024 | 25.46% |
| July 31, 2024 | 25.46% |
| Date | Value |
|---|---|
| June 30, 2024 | 25.46% |
| May 31, 2024 | 25.46% |
| April 30, 2024 | 25.46% |
| March 31, 2024 | 25.46% |
| February 29, 2024 | 25.46% |
| January 31, 2024 | 25.92% |
| December 31, 2023 | 27.07% |
| November 30, 2023 | 33.99% |
| October 31, 2023 | 33.99% |
| September 30, 2023 | 33.99% |
| August 31, 2023 | 33.99% |
| July 31, 2023 | 33.99% |
| June 30, 2023 | 33.99% |
| May 31, 2023 | 33.99% |
| April 30, 2023 | 33.99% |
| March 31, 2023 | 33.99% |
| February 28, 2023 | 33.99% |
| January 31, 2023 | 33.99% |
| December 31, 2022 | 33.99% |
| November 30, 2022 | 33.99% |
| October 31, 2022 | 33.99% |
| September 30, 2022 | 33.99% |
| August 31, 2022 | 33.99% |
| July 31, 2022 | 33.99% |
| June 30, 2022 | 33.99% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| CASI Pharmaceuticals, Inc. | 99.54% |
| CanSino Biologics, Inc. | 96.53% |
| Shanghai Junshi Biosciences Co., Ltd. | 91.68% |
| Ascletis Pharma, Inc. | 99.82% |
| CStone Pharmaceuticals Co. Ltd. | 95.44% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 46.07 |
| Beta (5Y) | 0.7764 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 395.1% |
| Historical Sharpe Ratio (5Y) | 0.1347 |